Orbimed Advisors - ACHILLES THERAPEUTICS PLC ownership

ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 30 filers reported holding ACHILLES THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ACHILLES THERAPEUTICS PLC
ValueSharesWeighting
Q3 2022$3,307,000
-17.2%
1,463,251
-7.7%
0.06%
-15.3%
Q2 2022$3,994,000
-14.3%
1,584,8450.0%0.07%
-5.3%
Q1 2022$4,659,000
-41.3%
1,584,8450.0%0.08%
-25.5%
Q4 2021$7,940,000
-35.7%
1,584,8450.0%0.10%
-25.0%
Q3 2021$12,346,000
-20.4%
1,584,8450.0%0.14%
-13.4%
Q2 2021$15,516,000
-40.8%
1,584,8450.0%0.16%
-35.9%
Q1 2021$26,229,0001,584,8450.24%
Other shareholders
ACHILLES THERAPEUTICS PLC shareholders Q1 2021
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 11,086,909$10,087,97915.03%
Artal Group S.A. 2,255,375$2,0520.09%
Redmile Group, LLC 1,608,089$1,463,2000.07%
Forefront Analytics, LLC 78,169$71,1260.04%
Baker Brothers Advisors 2,557,149$2,326,7500.01%
Point72 Asset Management, L.P. 1,413,809$1,286,4250.00%
XTX Topco Ltd 21,084$19,1840.00%
Coppell Advisory Solutions LLC 1,000$5,5600.00%
Renaissance Technologies 437,528$3980.00%
JPMORGAN CHASE & CO 989$9000.00%
View complete list of ACHILLES THERAPEUTICS PLC shareholders